These variables comprised LVEF, estimated Glomerular Filtration Rate (eGFR), fasting blood glucose levels, duration of diabetes mellitus (DM), history of previous coronary artery disease (CAD), TG levels, usage of oral anti-hyperglycemic agents, and insulin therapy. This evidence concerns the gene INS and diabetes mellitus.